Anti-obesity therapeutics potential of plant genetic resources of Bangladesh and their conservation at Bangladesh Agricultural University Botanical Garden

preprint OA: closed
Full text JSON View at publisher
Full text 2,165 characters · extracted from oa-doi-fallback · click to expand
This is a Preprint and has not been peer reviewed. This is version 1 of this Preprint. You must log in to post a comment. There are no comments or no comments have been made public for this article. This is a Preprint and has not been peer reviewed. This is version 1 of this Preprint. Add a Comment You must log in to post a comment. Comments There are no comments or no comments have been made public for this article. Obesity, a global health issue affecting 650 million people, leads to chronic diseases and health impairments. Anti-obesity drugs are expensive and may cause side effects, raising significant concerns. One hundred eighty-eight medicinal plant species from 157 genera and 62 families in Bangladesh exhibit anti-obesity activity. Fabaceae (syn. Leguminosae) is the largest family, consisting of 25 species, while Citrus is the largest genus with seven species. The leaf is the most commonly used plant part, followed by the fruit. Plant secondary metabolites, including acids, alkaloids, terpenoids, saponins, glycosides, tannins, carboxylic acids, (poly)phenols, and flavonoids, serve as effective interventions in a complex system approach to obesity. Among these medicinal plants, 110 species are conserved at the Bangladesh Agricultural University (BAU) Botanical Garden, and more than 50 species are cultivated on BAU farms and in homestead gardens. Twenty species are conserved both in the Botanical Garden and cultivated as field/horticultural crops and ornamentals. According to the IUCN Red List of Threatened Taxa, the current (global) status of these species is data deficient for 11, least concern for 73, near threatened for 1, vulnerable for 3, endangered for 2, and no assessment has yet been performed for 98 species. Future studies should focus on enhancing efficacy and reducing the side effects of conventional anti-obesity medications. https://doi.org/10.32942/X2495V Life Sciences Thermodynamic imbalance, secondary metabolites, anti-obesity, IUCN Red List Published: 2026-04-13 02:44 Last Updated: 2026-04-13 02:44 CC BY Attribution 4.0 International Conflict of interest statement: No conflict of interest Language: English

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00